The Prophylactic Effect of Levosimendan in Reducting Acute Kidney Injury Postoperatively in Pediatric Patients Undergoing Corrective Heart Surgery

Trial Profile

The Prophylactic Effect of Levosimendan in Reducting Acute Kidney Injury Postoperatively in Pediatric Patients Undergoing Corrective Heart Surgery

Completed
Phase of Trial: Phase II

Latest Information Update: 19 May 2017

At a glance

  • Drugs Levosimendan (Primary) ; Milrinone
  • Indications Acute kidney injury; Postoperative complications
  • Focus Therapeutic Use
  • Acronyms MiLe-1
  • Most Recent Events

    • 25 Apr 2017 Status changed from recruiting to completed.
    • 18 Aug 2016 Planned End Date changed from 1 Oct 2016 to 1 Jan 2017.
    • 18 Aug 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Jan 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top